Fox Run Management’s Collegium Pharmaceutical COLL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-5,401	Closed	-$210K	–	822
2024 Q1	$210K	Buy	+5,401	New	+$210K	0.05%	622
2018 Q2	–	Sell	-8,634	Closed	-$221K	–	704
2018 Q1	$221K	Buy	+8,634	New	+$221K	0.05%	598